- $75.28m
- $72.01m
- $32.03m
electroCore, Inc. reports results for the quarter ended in December - Earnings Summary
Brief: electroCore Q4 Net Income USD -4.032 Million
electroCore, Inc. expected to post a loss of 61 cents a share - Earnings Preview
electroCore, Inc. expected to post a loss of 61 cents a share - Earnings Preview
Brief: Electrocore Expands Intellectual Property Portfolio
Brief: ElectroCore- Size Of Board Was Increased From Seven Members To Eight
Brief: Electrocore Issued Patent For System Stimulating Nerve Target In Head Or Neck
Brief: electroCore Q3 Net Income USD -4.032 Million
Brief: electroCore Announces Two-Year Extension Of gammaCore Device Listing In The NHS Supply Chain Catalogue
Brief: Electrocore "Vanquish" Clinical Trial Suggests Safety & Efficacy Of NVNS For Treatment Of Headache Associated With Subarachnoid Hemorrhage
Brief: Electrocore Expands Intellectual Property Portfolio For Non-Invasive Vagus Nerve Stimulation (Nvns) Technology
electroCore, Inc. reports results for the quarter ended in June - Earnings Summary
Brief: electroCore, Inc. Sees FY revenue USD 14-15 million
Brief: Electrocore Says By Resolution Of Board, Size Of Board Has Been Decreased To Seven Members As Of Aug 4
electroCore, Inc. expected to post a loss of 96 cents a share - Earnings Preview
Brief: electroCore Inc Announces $8.145 Mln Registered Direct Offering
electroCore, Inc. expected to post a loss of 94 cents a share - Earnings Preview
Brief: electroCore Expands Intellectual Patent Portfolio For nVNS Technology
Brief: electroCore Announces Distribution Agreement With Reliefband Technologies